相关实验视频
Updated: Jul 24, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.4K
压力心肌病症多胞体移植后:一个病例报告
Fouad G Souki1, Nicolas Caram1, Eslam Fouda1
1Anesthesiology, Jackson Memorial Hospital, University of Miami, Miami, USA.
Cureus
|March 14, 2025
概括
本病例报告详细介绍了多胞体移植 (MVT) 后的应激心肌病 (Takotsubo综合征). 早期诊断和管理导致了这一复杂的外科手术场景的良好结果.
科学领域:
- 心脏病学 心脏病学
- 移植手术 移植手术
- 关键护理医学 关键护理医学
背景情况:
- 多胞体移植 (MVT) 是一项复杂的手术,伴随着显著的生理压力.
- 血液动力学不稳定,流体转移和MVT期间出血可能会影响心血管功能.
- 压力心肌病 (Takotsubo综合征) 是已知的重大手术并发症,但在MVT中没有特征.
研究的目的:
- 在接受MVT的患者中报告第一个应激心肌病变的病例.
- 描述这种并发症的诊断,术后管理和结果.
- 强调在MTV患者中识别和管理压力心肌病的重要性.
主要方法:
- 一个患者的病例报告,该患者接受了MVT,手术内有毒的体外膜氧化.
- 应力心肌病的诊断基于临床表现,心声学和InterTAK得分.
- 根据患者的病情量身定制的外科手术期间的管理策略.
主要成果:
- 患者在MVT期间发展了应激心肌病.
- 心声扫描证实了急性左心室功能障碍与塔科苏博综合征相一致.
- 患者接受了适当的治疗,并取得了良好的结果.
结论:
- 在MVT的背景下,压力心肌病也可能发生.
- 提高临床意识和及时诊断对于有利的结果至关重要.
- 这一案例强调了对MVT心脏并发症的警的必要性.
相关概念视频
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

